Leidos Holdings, Inc. $LDOS Shares Sold by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company lowered its stake in Leidos Holdings, Inc. (NYSE:LDOS) by 5.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 63,556 shares of the aerospace company’s stock after selling 3,656 shares during the quarter. The Manufacturers Life Insurance Company owned about 0.05% of Leidos worth $6,544,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Bryn Mawr Trust Advisors LLC raised its position in shares of Leidos by 4.8% during the 4th quarter. Bryn Mawr Trust Advisors LLC now owns 1,337 shares of the aerospace company’s stock worth $241,000 after buying an additional 61 shares in the last quarter. Cullen Frost Bankers Inc. boosted its holdings in shares of Leidos by 19.4% in the fourth quarter. Cullen Frost Bankers Inc. now owns 381 shares of the aerospace company’s stock valued at $69,000 after acquiring an additional 62 shares in the last quarter. Keybank National Association OH boosted its holdings in shares of Leidos by 3.6% in the fourth quarter. Keybank National Association OH now owns 1,855 shares of the aerospace company’s stock valued at $335,000 after acquiring an additional 65 shares in the last quarter. Glenmede Investment Management LP increased its stake in shares of Leidos by 3.2% during the third quarter. Glenmede Investment Management LP now owns 2,240 shares of the aerospace company’s stock valued at $423,000 after acquiring an additional 69 shares during the period. Finally, HighPoint Advisor Group LLC raised its holdings in Leidos by 0.9% during the fourth quarter. HighPoint Advisor Group LLC now owns 7,635 shares of the aerospace company’s stock worth $1,377,000 after purchasing an additional 70 shares in the last quarter. Institutional investors own 76.12% of the company’s stock.

Leidos Trading Down 0.0%

Shares of NYSE LDOS opened at $140.59 on Monday. The company has a quick ratio of 1.60, a current ratio of 1.63 and a debt-to-equity ratio of 1.13. Leidos Holdings, Inc. has a 12 month low of $98.86 and a 12 month high of $205.77. The company has a market cap of $17.64 billion, a price-to-earnings ratio of 13.11, a P/E/G ratio of 2.05 and a beta of 0.52. The business has a fifty day simple moving average of $119.90 and a 200-day simple moving average of $139.03.

Leidos (NYSE:LDOS) last released its quarterly earnings results on Tuesday, August 4th. The aerospace company reported $3.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.91 by $0.35. Leidos had a net margin of 7.80% and a return on equity of 30.81%. The business had revenue of $4.56 billion for the quarter, compared to analyst estimates of $4.44 billion. During the same quarter in the previous year, the business earned $3.21 earnings per share. The firm’s revenue was up 7.2% compared to the same quarter last year. Leidos has set its FY 2026 guidance at 12.200-12.500 EPS. Sell-side analysts predict that Leidos Holdings, Inc. will post 12.38 EPS for the current year.

Leidos Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Tuesday, September 15th will be given a $0.43 dividend. This represents a $1.72 annualized dividend and a dividend yield of 1.2%. The ex-dividend date of this dividend is Tuesday, September 15th. Leidos’s dividend payout ratio (DPR) is 16.04%.

Leidos announced that its board has initiated a share repurchase program on Friday, July 31st that authorizes the company to repurchase 20,000,000 shares. This repurchase authorization authorizes the aerospace company to repurchase shares of its stock through open market purchases. Shares repurchase programs are typically a sign that the company’s board of directors believes its shares are undervalued.

Analyst Ratings Changes

A number of brokerages have issued reports on LDOS. TD Cowen increased their price target on Leidos from $115.00 to $135.00 and gave the company a “hold” rating in a research note on Friday, August 7th. Robert W. Baird set a $150.00 price objective on Leidos in a research note on Wednesday, August 5th. Wall Street Zen raised Leidos from a “hold” rating to a “buy” rating in a research note on Thursday, July 16th. Wells Fargo & Company set a $165.00 target price on Leidos in a report on Monday, August 17th. Finally, Weiss Ratings cut shares of Leidos from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, June 8th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and ten have issued a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $162.93.

Insider Activity at Leidos

In other news, Director Noel B. Geer sold 10,000 shares of Leidos stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $140.66, for a total transaction of $1,406,600.00. Following the transaction, the director owned 34,274 shares in the company, valued at approximately $4,820,980.84. The trade was a 22.59% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.77% of the stock is currently owned by company insiders.

About Leidos

Leidos is an American technology and engineering company that provides services and solutions to government and commercial customers, with a strong focus on national security, defense, intelligence, and civil government markets. The company delivers systems integration, engineering, cybersecurity, software development, data analytics, cloud migration and managed IT services, as well as mission support for complex programs. Leidos’ work spans areas such as C4ISR (command, control, communications, computers, intelligence, surveillance and reconnaissance), secure communications, sensors and systems engineering, and health IT solutions for public-sector healthcare programs.

Leidos traces its corporate roots to Science Applications International Corporation (SAIC) and emerged as an independent, publicly traded company following a corporate separation in 2013.